Scroll to learn more

About Lung Cancer

Recognizing Symptoms of Lung Cancer 

Typically the symptoms and effects of lung cancer do not appear until the disease is advanced.4 When it does cause symptoms, those symptoms may be mistaken for those of less serious conditions. These include2 4:

  • Persistent coughing that either doesn’t go away or gets worse with time
  • Chest pain that often gets worse when coughing, laughing, or inhaling deeply
  • Wheezing/shortness of breath
  • Coughing up blood
  • Vocal raspiness
  • Feelings of fatigue or weakness
  • Weight loss or loss of appetite
  • Recurrent pneumonia or bronchitis

As lung cancer spreads outside of the lung tissue, additional symptoms may appear3 4 5:

  • Swelling in the upper chest, neck, and face or lumps near the surface of the body
  • Bone pain
  • Yellowing of the skin and eyes

Because lung cancer doesn’t always cause early symptoms, it’s important to contact your healthcare professional if you notice something unusual, especially if you are at higher risk. High-risk individuals (older adult who smoke tobacco, family history of the disease, people exposed to secondhand smoke or environmental pollutants and those with a genetic mutation) can also speak with their care team about regular screenings. You can learn more about the risk factors in the FAQs.

Lung Cancer Descriptions

There are two primary types of lung cancer: non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC) and NSCLC accounts for 85% of lung cancers, with SCLC representing the other 15% of cases.3

Non-Small Cell Lung Cancer (NSCLC)

Non-small cell lung cancer is the most common type of lung cancer. Subtypes include slower-growing cancers, such as adenocarcinoma, or faster-growing cancers like large cell carcinoma.

Small Cell Lung Cancer (SCLC)

Small cell lung cancer tends to grow aggressively and rapidly compared to NSCLC. Subtypes of SCLC include large cell neuroendocrine carcinoma and mesothelioma.

Frequently Asked Questions About Lung Cancer

What is lung cancer?

Lung cancer occurs when cells begin to multiply too quickly in your lungs, causing the formation of tumors. It typically forms in the airways and air sacs and can spread to other parts of the body. Lung cancer is the second most frequently diagnosed cancer after breast cancer, accounting for more than 2.2 million new cases in 2020 and around 11% of all new cancer diagnoses worldwide.

Lung cancer is often hard to catch in the early stages and is the leading cause of cancer deaths worldwide.10

What are the risk factors of lung cancer?

Smoking is the greatest risk factor for lung cancer and is linked to 80% of lung cancer deaths.2 4 Smoking risks are cumulative, meaning the more and the longer you smoke, the greater your risk. All types of smoking—cigarette, cigar, and pipe—increase your risk factor. If you don't smoke, secondhand smoke can still increase your risk of developing lung cancer.6

However, many people with no exposure to smoking can be at risk of lung cancer. Air pollution or exposure to hazardous materials such as radon, radioactive ores, and inhaled chemicals can cause lung cancer. In some parts of the world, arsenic may be present in drinking water, heightening lung cancer risks. If you have previously had lung cancer, or you have a family history of lung cancer, you are more likely to develop lung cancer.1 4

What should I do if I'm at high risk for lung cancer?

If you are at higher risk for lung cancer, your doctor might order regular screenings to detect abnormalities in the lungs. Regular screenings can help to identify cancer before symptoms start, improving the likelihood of effective treatment.1 2

It’s important to discuss your lung cancer risk with your physician, especially if you smoke, previously smoked, or have a family history of lung cancer. If you know of any exposure to hazardous materials that can cause lung cancer, you can also share this information with your medical team.

How is lung cancer diagnosed?

If your doctor suspects you have lung cancer, they will do a physical exam and discuss your symptoms. They may order imaging tests of your chest, blood and mucus tests, and a lung biopsy. If these tests come back positive for lung cancer, your medical team will conduct further tests to determine the stage of the cancer, including whether it has spread beyond the lungs. This information will help your care team determine an appropriate course of treatment.4 6

What is the difference between small cell lung cancer and non-small cell lung cancer?

Non-small cell lung cancer is more common, accounting for approximately 85% of all lung cancers. It also typically develops more slowly. Small cell lung cancer is aggressive, tends to spread quickly, and is often detected after it has migrated to other parts of the body. It is also harder to treat and may be more likely to recur.6 11

What are the stages of lung cancer?

Lung cancer staging is based on the size and position of the main tumor and the spread of the cancer to other parts of the body. Staging typically differs between SCLC and NSCLC, partially because SCLC is rarely caught in early stages.6 8

Small Cell Lung Cancer

  • Limited Stage – Cancer cells are generally still in the area where the cancer formed. They may have spread to local areas like the space between the lungs or to nearby lymph nodes.
  • Extensive Stage – Cancer has spread beyond both the lungs and local areas to other parts of the body.

Non-Small Cell Lung Cancer

  • Stage 0 – Cancer cells are present but have not penetrated beyond the top layer of cells within the air passages (bronchi and bronchioles) or to other parts of the body.
  • Stage I – Tumor has begun to penetrate the deeper lung tissues but remains small and has not spread beyond the lungs.
  • Stage II – Tumor has grown and become more deeply embedded within the lung structure. It may have spread to nearby lymph nodes.
  • Stage III – Tumor continues to grow within the lung and may have expanded into the chest area. It may have spread to multiple lymph nodes, including lymph nodes farther from the main tumor, but has not spread to distant parts of the body.
  • Stage IV – Cancer cells have metastasized to distant parts of the body.

What are common side effects of lung cancer treatment?

Side effects depend on the course of treatment. Fatigue, nausea, and vomiting are common. Chemotherapy patients may experience hair loss, diarrhea, or loss of sensation. Immunotherapy can cause diarrhea, along with rashes, and joint pain, while radiation therapy can cause coughing, difficulty swallowing, and shortness of breath. Talk to your provider about options for managing pain or other symptoms.2 There may be other side effects depending on the treatment, please consult your provider.

What is the prognosis for lung cancer?

Prognosis will depend on many factors, including the stage of diagnosis, the type and staging of the lung cancer, how well it responds to treatment, and your overall health and age. Lung cancer that remains localized when treatment begins is associated with better relative five-year survival rates.2 12

If lung cancer is no longer detected within your body, your healthcare team will continue to check to make sure the cancer has not returned, manage any side effects, and monitor your overall health.

This plan may include regular physical examinations and/or medical tests to monitor your recovery for the coming months and years. They will also watch for recurrence or second cancer.

Cancer recurs because small areas of cancer cells may remain undetected in the body. Over time, these cells may increase in number until they show up on test results or cause signs or symptoms. During follow-up care, a doctor familiar with your medical history can give you personalized information about your risk of recurrence.3

Are there new treatments for lung cancer?

Researchers are continuously investigating potential new and more effective treatments. For guidance on the best treatment options for you—and to determine if you may qualify for a clinical trial—please speak with your healthcare provider.

Sources:

1Mayo Foundation for Medical Education and Research. (2024, April 30). Lung cancer. https://www.mayoclinic.org/diseases-conditions/lung-cancer/symptoms-causes/syc-20374620

2Cleveland Clinic. (2022, October 31). Lung cancer. https://my.clevelandclinic.org/health/diseases/4375-lung-cancer

3American Cancer Society. (2025, February 27). Lung cancer. https://www.cancer.org/cancer/types/lung-cancer.html

4MedlinePlus, National Library of Medicine. (2025, May 5). Lung cancer. https://medlineplus.gov/lungcancer.html

5American Lung Association. (2024, October 1). Lung cancer basics. https://www.lung.org/lung-health-diseases/lung-disease-lookup/lung-cancer/basics

6National Cancer Institute. (2025, May 8). Small Cell Lung Cancer Treatment (PDQ) – Patient Version. https://www.cancer.gov/types/lung/patient/small-cell-lung-treatment-pdq

7National Cancer Institute. (2025, May 16). Non-Small Cell Lung Cancer Treatment (PDQ) – Patient Version. https://www.cancer.gov/types/lung/patient/non-small-cell-lung-treatment-pdq

8American Cancer Society. (2025, June 9). Non-small Cell Lung Cancer Stages. https://www.cancer.org/cancer/types/lung-cancer/detection-diagnosis-staging/staging-nsclc.html

9Kerr, K. M., Bibeau, F., Thunnissen, E., Botling, J., Ryška, A., Wolf, J., Öhrling, K., & Mino-Kenudson, M. (2021, April). The evolving landscape of biomarker testing for non-small cell lung cancer in Europe. Lung Cancer, 154, 161-175. https://www.lungcancerjournal.info/article/S0169-5002(21)00086-6/fulltext

10Sung, H., Ferlay, J., Siegel, R. L., Laversanne, M., Soerjomataram, I., Jemal, A., & Bray, F. (2021, February 4). Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer Journal for Clinicians, 71: 209–249. https://acsjournals.onlinelibrary.wiley.com/doi/10.3322/caac.21660

11Ganti, A. K., Loo, B. W., Bassetti, M. F., Borghaei, H., Chandra, R. A., Chow, L. Q. M., D'Amico, T. A., & et al. (2023, December). Non–small cell lung cancer, version 6.2023, NCCN clinical practice guidelines in oncology. Journal of the National Comprehensive Cancer Network, 19(12), 1441–1464. https://pmc.ncbi.nlm.nih.gov/articles/PMC10203822/

12National Cancer Institute. Surveillance, Epidemiology, and End Results Program. (n.d). Cancer stat facts: Lung and bronchus cancer. https://seer.cancer.gov/statfacts/html/lungb.html